(Q45170292)

10 December 2017

Candesartan reduced advanced glycation end-products accumulation and diminished nitro-oxidative stress in type 2 diabetic KK/Ta mice (English)

1 reference

10 December 2017

Qiuling Fan

1

1 reference

10 December 2017

Jie Liao

2

1 reference

10 December 2017

Michimasa Kobayashi

3

1 reference

10 December 2017

Michifumi Yamashita

4

1 reference

10 December 2017

Leyi Gu

5

1 reference

10 December 2017

Tomohito Gohda

6

1 reference

10 December 2017

Yusuke Suzuki

7

1 reference

10 December 2017

Li Ning Wang

8

1 reference

10 December 2017

Satoshi Horikoshi

9

1 reference

10 December 2017

Yasuhiko Tomino

10

1 reference

10 December 2017

language of work or name

English

0 references

publication date

1 December 2004

1 reference

Nephrology Dialysis Transplantation

10 December 2017

1 reference

10 December 2017

19

1 reference

10 December 2017

12

1 reference

10 December 2017

3012-3020

1 reference

Glucose, glycation, and RAGE: implications for amplification of cellular dysfunction in diabetic nephropathy

10 December 2017

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH499

Requirement for p38 and p44/p42 mitogen-activated protein kinases in RAGE-mediated nuclear factor-kappaB transcriptional activation and cytokine secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH499

Oxidative stress and nitric oxide synthase in rat diabetic nephropathy: effects of ACEI and ARB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH499

Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH499

Angiotensin II receptor antagonists and angiotensin-converting enzyme inhibitors lower in vitro the formation of advanced glycation end products: biochemical mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH499

Anti-Hypertensive Agents Inhibit In Vivo the Formation of Advanced Glycation End Products and Improve Renal Damage in a Type 2 Diabetic Nephropathy Rat Model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH499

Reduction of the accumulation of advanced glycation end products by ACE inhibition in experimental diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH499

Susceptibility and negative epistatic loci contributing to type 2 diabetes and related phenotypes in a KK/Ta mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH499

Gene expression profile in diabetic KK/Ta mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH499

Intrarenal localization of nitric oxide synthase isoforms and soluble guanylyl cyclase

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH499

Paradoxes of nitric oxide in the diabetic kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH499

Peroxynitrite induces formation of N( epsilon )-(carboxymethyl) lysine by the cleavage of Amadori product and generation of glucosone and glyoxal from glucose: novel pathways for protein modification by peroxynitrite.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH499

Role of receptor for advanced glycation end-product (RAGE) and the JAK/STAT-signaling pathway in AGE-induced collagen production in NRK-49F cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH499

21 January 2018

Identifiers

DOI

10.1093/NDT/GFH499

1 reference

10 December 2017

1 reference